Spruce Biosciences, Inc.
Spruce Biosciences, Inc.（SPRB）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
sprb · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$283
Consensus
$191
+287.3% upside
Low
$140
Median: $150 · Last Close: $49.32
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$191.00
287.3% upside
High Target
$283
473.8%
Low Target
$140
183.9%
Current Price
$49.32
as of today
Based on analyst price targets, the SPRB stock price prediction for the next 12 months ranges from $140 to $283. The consensus SPRB price forecast of $191.00 implies 287.3% upside from the current price of $49.32.
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $48.29 | ↓ 2.08% |
1-day model range: $47.46–$49.12. Peak: $49.12 (-2.08%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · SPRB · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-14 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-10 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-02-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-03 | Leerink Partners | Upgrade ↑ | Market Perform→Outperform |
| 2025-11-11 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-10-28 | JMP Securities | Upgrade ↑ | Market Perform→Market Outperform |
| 2025-10-21 | Leerink Partners | Maintains | Market Perform→Market Perform |
| 2025-04-16 | RBC Capital | Maintains | Sector Perform→Sector Perform |
Wall Street analysts have recently issued updated ratings on Spruce Biosciences, Inc. (SPRB) stock. Of the recent 52 rating actions, 3 were upgrades and 9 were downgrades. 11 analysts currently cover SPRB.
分析师推荐趋势
SPRB analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$54M
↑ 160.6% YoY
Revenue Next Year
$76M
↑ 41.6% YoY
EPS This Year
$-22.85
EPS Next Year
$-3.87
↓ 83.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast SPRB EPS of $-22.85 for the current fiscal year, based on estimates from 3 analysts. The SPRB revenue forecast is $54M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
SPRB 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。SPRB 的共识目标价为 $191.00（+287.3% 上行空间），分析师共识为 Buy。
SPRB 的短期预测（明日）为 $48.29（-2.08%）。
Spruce Biosciences, Inc. 在 NASDAQ 上市，代码 SPRB。SPRB 在 2027 年的整体展望偏积极，在覆盖分析师中约 55% 对应 Buy 共识。
常见问题
SPRB 预测 · 8 个问题根据 11 位华尔街分析师，SPRB 的 12 个月平均目标价为 $191.00，最高 $283.00、最低 $140.00。若有图表，中位目标价可在上方查看。相对当前价 $49.32，隐含约 +287.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.